The Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
NCT06990126 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-01-06
Summary
A multicenter, retrospective, real-world stduy . Subjects with composite criteria were teated with eravacycline ,and 100 cases ,Tigecycline and 300 cases were to be enrolled.
Conditions
- Clinical Efficacy and Safety
Interventions
- DRUG
-
bronchoscope
We will perform bronchoscopy and collect bronchoalveolar lavage fluid(BALF)
Sponsors & Collaborators
-
The First Affiliated Hospital with Nanjing Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2026-07-30
- Completion
- 2026-07-30
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Evaluating a Novel Individualised Treatment Strategy for Carbapenem-Resistant Gram-Negative Bacteria Infections
NCT04202861 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS Infection
NCT06223100 ·Status: NOT_YET_RECRUITING
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
MDR Bacilli Surveillance and Clinical Feature in China
NCT02140853 ·Status: UNKNOWN
-
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
NCT06174649 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
NCT01222832 ·Status: COMPLETED ·Phase: PHASE2
-
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
NCT01212601 ·Status: COMPLETED
-
Clinical Evaluation of the Residual Antimicrobial Activity
NCT04495920 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics
NCT01311349 ·Status: COMPLETED
-
A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections
NCT02355015 ·Status: UNKNOWN
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
NCT05695196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii
NCT01342731 ·Status: UNKNOWN ·Phase: PHASE4
-
Volatile Organic Compounds in Staphylococcus Aureus Patients
NCT01379053 ·Status: COMPLETED
-
NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis
NCT04257292 ·Status: UNKNOWN
-
Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)
NCT03630250 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment
NCT06805994 ·Status: RECRUITING ·Phase: PHASE1
-
6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province
NCT07198685 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
NCT01072539 ·Status: COMPLETED
-
Antibiotics and Vaccine Immune Responses Study
NCT06148025 ·Status: RECRUITING ·Phase: PHASE4
-
Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus
NCT04469348 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Eravacycline Combination Therapy for MRAB
NCT06282835 ·Status: RECRUITING
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
Biotherapy for MRSA Enterocolitis
NCT02390622 ·Status: UNKNOWN ·Phase: NA